Profile: Fisher & Paykel Healthcare, Inc.


Fisher & Paykel Healthcare, a world leader in heated humidification systems, introduces Optiflow™ for Nasal High Flow Therapy. In your Emergency Department, Optiflow™ delivers humidified gas, with or without supplemental oxygen, at flows up to 60 L/min for the treatment of your respiratory compromise patients. Clinical evidence proves that early implementation of Nasal High Flow Therapy can reduce escalation and risk of intubation. Reducing therapy escalation to mechanical ventilation (intubation/NIV) can provide fewer ICU admissions, improved bed flow and reduced ED boarders.

  • Sam Aminpour
    National Accounts Manager
  • Clemmis Futrell
    Clinical Affairs Specialist
  • Chris Hutchinson
    Director of Clinical Affairs
  • Steve Lacke
    Vice President of Sales and Marketing
  • Steve Urquhart
    Director of Marketing
  • Steve Wilson
    National Sales Manager
[ Feedback → ]